CLPTM1L

Lipid scramblase CLPTM1L · Q96KA5 · CLPTM1L on Sugi Atlas →

0 patent compounds predicted against CLPTM1L, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CLPTM1L by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer PHASE4UNKNOWN
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma PHASE2COMPLETED
Effects of Cannabidiol (CBD) on the Activation of Autophagy and Inflammation Genes, Functional Consequences in Virologically Controlled HIV-infected Patients PHASE2COMPLETED
CLL Induction Treatment With Venetoclax and Ibrutinib, Followed by Ibrutinib and Obinutuzumab in Patients With MRD. PHASE2ACTIVE_NOT_RECRUITING
In Vivo Lithium Treatment Effects on Gene Expression Levels in Lymphoblastoid Cell Lines From Human Healthy Subjects PHASE1COMPLETED
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Efferocytosis and Genomic Polymorphism in Autoimmune Diseases nanUNKNOWN
Apoptosis Markers in Aggressive Periodontitis nanCOMPLETED
PCD New Gene Discovery nanCOMPLETED
Evaluation of Serum Gasdermin D Level As a Potential Biomarker of Disease Activity in Vitiligo Patients nanUNKNOWN
Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome nanRECRUITING
In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects nanUNKNOWN
Genes, Proteins, and Metabolites in Drug-resistant Epilepsy (DRE) Patients nanNOT_YET_RECRUITING
Autophagy Bladder Cancer nanUNKNOWN
Immune Cell Response to Stimuli nanRECRUITING
Pulmonary Hypertension, Hypoxia and Sickle Cell Disease nanCOMPLETED
Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients nanRECRUITING
Study of Autoimmune Lymphoproliferative Syndrome (ALPS) nanRECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
The Effect of Vitamin E-coated Polysulfone Membrane on Oxidative Stress, Inflammation and Monocytes in Critically Ill Patients in CRRT nanUNKNOWN
Novel Genetic Disorders of the Immune System nanRECRUITING
Autophagy/Apoptosis Balance in Placental Vascular Pathologies nanRECRUITING
Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma nanSUSPENDED
Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia nanCOMPLETED
Role of USP35 in the Detection of Ferroptosis in Juvenile Autoimmune Hepatitis nanNOT_YET_RECRUITING
Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women nanCOMPLETED
Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's Disease nanWITHDRAWN
Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Parkinson's Disease nanWITHDRAWN

Related proteins — ESM-2 sequence neighbours (a CLPTM1L binder may also engage these)

ProteinNameSimilarity
A2VE61 1.000 A2VE61 →
Q5R7B1 1.000 Q5R7B1 →
Q8BXA5 1.000 Q8BXA5 →
Q5ZKJ0 0.992 Q5ZKJ0 →
Q6DHU1 0.972 Q6DHU1 →
Q0VCK9 0.967 Q0VCK9 →
Q99KU0 0.965 Q99KU0 →
Q5R9K4 0.962 Q5R9K4 →
Q91ZQ0 0.961 Q91ZQ0 →
Q6DD32 0.960 Q6DD32 →
Q6P360 0.960 Q6P360 →
VMP1 Vacuole membrane protein 1 0.960 landscape →
Q6NYY9 0.959 Q6NYY9 →
Q940S0 0.958 Q940S0 →
Q5U4X8 0.956 Q5U4X8 →
Q9H920 0.955 Q9H920 →
A9JRA0 0.955 A9JRA0 →
Q68EQ9 0.955 Q68EQ9 →
Q8WVP7 0.955 Q8WVP7 →
Q6INE8 0.955 Q6INE8 →
Q923S8 0.954 Q923S8 →
Q9EQH7 0.954 Q9EQH7 →
Q9TU72 0.953 Q9TU72 →
Q9ZPS7 0.953 Q9ZPS7 →
Q3TA38 0.953 Q3TA38 →
Q5R5F8 0.953 Q5R5F8 →
E1BD52 0.952 E1BD52 →
Q9QZ71 0.952 Q9QZ71 →
Q8CIF6 0.952 Q8CIF6 →
CDS2 Phosphatidate cytidylyltransferase 2 0.952 landscape →